Index 
 Previous 
 Next 
 Full text 
Procedure : 2016/2902(RSP)
Document stages in plenary
Select a document :

Texts tabled :

O-000135/2016 (B8-1818/2016)

Debates :

PV 14/12/2016 - 24
CRE 14/12/2016 - 24

Votes :

Texts adopted :


Minutes
Wednesday, 14 December 2016 - Strasbourg

24. Paediatric medicines (debate)
CRE

Question for oral answer (O-000135/2016) by Giovanni La Via, Françoise Grossetête, Elena Gentile, Bolesław G. Piecha, Frédérique Ries, Stefan Eck and Joëlle Mélin, on behalf of the ENVI Committee, Review of the regulation on paediatric medicines (2016/2902(RSP)) (B8-1818/2016)

Giovanni La Via moved the question.

Vytenis Povilas Andriukaitis (Member of the Commission) answered the question.

The following spoke: Françoise Grossetête, on behalf of the PPE Group, Elena Gentile, on behalf of the S&D Group, Stefan Eck, on behalf of the GUE/NGL Group, Piernicola Pedicini, on behalf of the EFDD Group, Miroslav Mikolášik, Soledad Cabezón Ruiz, John Stuart Agnew, Michaela Šojdrová and Claude Rolin.

The following spoke under the catch-the-eye procedure: Notis Marias and Nicola Caputo.

The following spoke: Vytenis Povilas Andriukaitis.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Giovanni La Via, Françoise Grossetête, Elena Gentile, Bolesław G. Piecha, Frédérique Ries, Stefan Eck and Joëlle Mélin, on behalf of the ENVI Committee, on the regulation on paediatric medicines (2016/2902(RSP)) (B8-1340/2016).

The debate closed.

Vote: minutes of 15.12.2016, item 6.7.

Legal notice - Privacy policy